Serum alkaline phosphatase and 30-day mortality after surgery for spinal metastatic disease

[1] Barzilai O(2017)Integrating evidence-based medicine for treatment of spinal metastases into a decision framework: neurologic, oncologic, mechanicals stability, and systemic disease J Clin Oncol 35 2419-2427

[2] Laufer I(2004)Mechanisms of bone metastasis N Engl J Med 350 1655-1664

[3] Yamada Y(2005)Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial Lancet 366 643-648

[4] Roodman GD(2016)Prognostic factors and skeletal-related events in patients with small cell lung cancer with bone metastases at the time of diagnosis Oncology 90 103-111

[5] Patchell RA(2010)Prognostic factors for skeletal complications from metastatic bone disease in breast cancer Breast Cancer Res Treat 123 767-779

[6] Tibbs PA(2007)The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies PLoS Med 4 e296-235

[7] Regine WF(2015)Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement BMC Med 13 1-E655

[8] Kang EJ(2006)REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229-490

[9] Lee SY(2018)Practical guide to surgical data sets: national surgical quality improvement program (NSQIP) and pediatric NSQIP JAMA Surg 43 E648-e1106

[10] Kim HJ(2017)National databases for neurosurgical outcomes research: options, strengths, and limitations Neurosurgery 16 482-36

[1] Barzilai O(2017)Integrating evidence-based medicine for treatment of spinal metastases into a decision framework: neurologic, oncologic, mechanicals stability, and systemic disease J Clin Oncol 35 2419-2427

[2] Laufer I(2004)Mechanisms of bone metastasis N Engl J Med 350 1655-1664

[3] Yamada Y(2005)Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial Lancet 366 643-648

[4] Roodman GD(2016)Prognostic factors and skeletal-related events in patients with small cell lung cancer with bone metastases at the time of diagnosis Oncology 90 103-111

[5] Patchell RA(2010)Prognostic factors for skeletal complications from metastatic bone disease in breast cancer Breast Cancer Res Treat 123 767-779

[6] Tibbs PA(2007)The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies PLoS Med 4 e296-235

[7] Regine WF(2015)Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement BMC Med 13 1-E655

[8] Kang EJ(2006)REporting recommendations for tumor MARKer prognostic studies (REMARK) Breast Cancer Res Treat 100 229-490

[9] Lee SY(2018)Practical guide to surgical data sets: national surgical quality improvement program (NSQIP) and pediatric NSQIP JAMA Surg 43 E648-e1106

[10] Kim HJ(2017)National databases for neurosurgical outcomes research: options, strengths, and limitations Neurosurgery 16 482-36